Purpose: We performed this study to evaluate the clinical presentation as well as the proper surgical intervention for ovarian metastasis from gastric cancers and these tumors were identified during postoperative follow-up. This will help establish the optimal strategy for improving the survival of patients with this entity. Materials and Methods: 22 patients (3.2%) with ovarian metastasis were noted when performing a retrospective chart review of (693) females patients who had undergone a resection for gastric cancer between 1981 and 2008. The covariates used for the survival analysis were the patient age at the time of ovarian relapse, the size of the tumor, the initial TNM stage of the gastric cancer, the interval to metastasis and the presence of gross residual disease after treatment for Krukenberg tumor. The cumulative survival curves for the patient groups were calculated with the Kaplan-Meier method and they were compared by means of the Log-Rank test. Results: The average age of the patients was 48.6 years (range: 24 to 78 years) and the average survival time of the 22 patients was 18.8 months (the estimated 3-year survival rate was 15.8%) with a range of 2 to 59 months after the diagnosis of Krukenberg tumor. The survival rate for patients without gross residual disease was longer than that of the patients with gross residual disease (P=0.0003). In contrast, patient age, the size of ovarian tumor, the initial stage of gastric adenocarcinoma, the interval to metastasis and adjuvant chemotherapy were not prognostic indicators for survival after the development of ovarian metastasis. Conclusions: Early diagnosis and complete resection are the only possible hope to improve survival. As the 3-year survival rate after resection of Krukenberg tumor is 15.8%, it seems worthwhile to consider performing tumorectomy as the second cytoreduction.
Introduction
The prognosis of ovarian metastases or Krukenberg tumor is known to be poor. Different from the West, it is not rare disease in Korea as it is tumor that has metastasized from gastric cancer and gastric cancer is prevalent in Korea. Krukenberg tumor occur in 0.3~6.7% of the operated gastric cancer patients, and its incidence is much higher in the autopsies of gastric cancer patients (33~41%).
(1,2) Numerous studies on Krukenberg tumor have been reported in Korea and other countries, nonetheless, most of them are on synchronous Krukenberg tumors, and there are relatively few studies on the incidence and treatment outcomes of metachronous Krukenberg tumor that developed during the postsurgical followup observation period. It has been reported that the incidence of Krukenberg tumor detected during the follow-up observation period after radical gastric resection or the second surgery is 3~4.4％, the median survival time is 12.4~17 months, (3, 4) and the inci dence and prognosis are slightly different depending on the reports. Therefore, we analyzed the incidence of Krukenberg tumor that developed during the follow-up observation period after the resection of the primary gastric cancer, and the clinicopathological features of the Krukenberg tumors were confirmed by the second surgery. The treatment methods, the survival rate and the factors mediating effects on them were examined. 
Materials and Methods
Among the 41 patients who were pathologically diagnosed with Krukenberg tumor after the second surgery at the Department of Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine during 27 years from 1981 to 2008, this study was conducted on 22 patients who were considered to have Krukenberg tumor that metastasized from gastric cancer, based on the history of surgery for gastric cancer. First, the incidence of Krukenberg tumor that originated from gastric cancer after gastrectomy was examined by assessing the number of female patients who underwent surgery for gastric cancer during the same period.
In addition, the age of onset of the 22 Krukenberg tumor patients, the menopause status, the tumor markers, the tumor node metastasis (TNM) disease stage according to the American Joint Committee on Cancer (AJCC) 6th edition(5) and the presence of factors that could mediate effects on the survival rate were examined by retrospectively assessing the histopathological grade of cell differentiation, the interval from the first surgery to the development of tumor, the surgical methods for Krukenberg tumor, whether or not more than 4 cycles of adjuvant chemotherapy was performed and the survival rate after the second surgery, based on the medical records. The follow-up observation of the patients was performed using the database at the outpatient department or by telephone follow-ups, and the mean follow-up period was 25.２ months. The survival rate of the Krukenberg tumor patients was analyzed by the Kaplan-Meier method and the Log-Rank test, and P-values＜0.05 were determined to be significant. All the statistical analyses were performed using the SPSS for Windows 12.0.
Results
The Krukenberg tumor patients were confirmed by the second surgery after the primary surgery for gastric cancer, and 22 patients were thought to have ovarian tumor that metastasized from gastric cancer. In regard to the primary cancer of the 41 Krukenberg tumor patients diagnosed after the second surgery during the same period, 53.7% of them had gastric cancer. In addition, there were 693 female patients who received gastrectomy after the diagnosis of gastric cancer during the same period and so the incidence of Krukenberg tumor that developed during the follow-up period after gastrectomy was 3.2%.
As for the major symptoms of Krukenberg tumor, lower abdominal discomfort and intermittent abdominal pain were noted in 10 cases (45.5%), no symptoms other than the detection of an ovarian mass by abdominal ultrasonography during regular physical check-ups was noted in ６cases (27.3%), palpation of a mass in the lower abdomen was noted in 4 cases (18.2%) and abdominal distention associated with ascites, abscess within the pelvis and fever was noted in one case each (4.5%). As for the diagnostic method, except for 1 patient with an intrapelvic abscess, 21 cases (95.5%) were diagnosed with an ovarian mass that was suspicious to be malignant by the abdominal sonography and abdominal CT performed prior to the second surgery. These patients and their masses were subsequently definitely diagnosed by examining the frozen sections during surgery.
The interval from the first surgery to the resurgery for Krukenberg tumor was on average 16.5 months (range: 3~34 months).
The mean age of the patients was 48.6 years (range: 24~78 years), there were 7 cases of T1 (31.8%), there were 6 case of T2a/2b (27.3%), there were 7 cases of T3 (73.8%) and 1 case of T4 (4.5%).
Regarding lymphovascular involvement, there were 5 cases of N0 (22.7%), 9 cases of N1 (40.9%) and 1 case of (4.5%). Regarding the histologic grade, 10 patients had moderately differentiated tumor (45.5%) and 8 patients had well differentiated tumor (36.4%).
As for the clinical characteristics of Krukenberg tumor, the average long axis was 12.9 cm (range: 4.6~18.０cm), 18 patients had bilateral tumors (81.8%) and 4 patients had unilateral tumor (18.2%).
As the recurrence patterns, 11 patients had tumor limited to the ovary (50.0%), 5 patients recurred within the pelvic cavity (22.7%) and 6 patients' tumor had metastasized to organs other than the abdomen and the pelvis (27.3%). Concerning surgical treatments, laparotomy was performed on all 22 patients, and bilateral oophorectomy was performed on all 22 patients. Hysterectomy was performed simultaneously on 10 patients, including 5 patients for whom invasion to the uterus was suspected. There were 14 patients without macroscopic residual tumors after tumor resection (63.6%). (Table 1) .
Among all 22 patients, 9 patients were tested for two tumor markers, serum CEA and CA-125, which may be of help to make an early diagnosis of Krukenberg tumor. Of the 9 patients, the CA-125 level was shown to be higher than normal (normal: lower than 35 U/ml) in 8 patients out of the 9 patients (88.9%), and the average value was 45.5 ±25.3 U/ml. The CEA was elevated in 1 patient (11.1%) to 16.2 ng/ ml, which was slightly high, and the rest of the patients were within the normal range (normal: lower than 10 ng/ml).
Discussion
The metastasis mechanism of Krukenberg tumor is particular, for example, it has been reported to develop even after the radical resection of early gastric cancer,(6) and so we studied the clinical characteristics, including the metastasis patterns. It has been reported that Krukenberg tumor is rare and its prognosis is poor, Fig. 1 . Overall survival curves for the patients with Krukenberg tumor from gastric cancer. The patients without gross residual disease survived longer than the patients with gross residual disease (P=0.0003). Among these 81 patients, 80% had early gastric cancer, which
shows that the disease stage of the diagnosed gastric cancer has become substantially lower.
Krukenberg tumor was reported for the first time in 1896 by
Freidrich Ernst Krukenberg. Afterward, the definition of the disease and the diagnostic criteria were very confusing. Initially, all metastatic ovarian cancers were termed as Krukenberg tumor.
Since the confusion was induced by the term, Novak and Gray (8) in 1938 was only one patients case in whom typical ascites was detected by a physical examination, and other than that, most early symptoms were lower abdominal pain, discomfort, etc. and they were considered to be nonspecific symptoms, so making the early diagnosis was difficult, and this may lower the postsurgical survival rate.
Therefore, the most important factor for allowing the complete re- Concerning the prognosis of Krukenberg tumor, the radical resection of Krukenberg tumor without leaving macroscopic residual lesions is difficult in many cases, and it has been reported that the median duration of survival ranges from 7.7 to 14.0 months. (1, 3, 13) In our study, the average survival rate was 18.8 months and this includes 2 patients who are still alive 22 and 59 months after surgery, the overall 3-year survival rate was approximately 15.7% and the prognosis was not good, but it was better than that of other reports.
The reasons that the survival rate in our study were slightly high may be diverse, yet it may be due to the proportion of patients incidentally detected during physical examination. So an early diagnosis was possible for ６ patients, and the patients for whom com- plied as a marker of ovarian cancer and this is of help to make the early diagnosis of Krukenberg tumor.(2) In our study, there were only 2 patients (9.1%) with the rapid increase of the CA-125 level to higher than 100 U/ml and the percentage of patients with a higher than average value were only 45.5%, and so this marker was not of great help. As compared with the observation that the CEA and CA 19-9 levels were not changed in most patients, among 9 patients for whom the measurement of CA-125 was performed, it was shown to be elevated in 8 patients. Since CA-125 was helpful to predict the development of Krukenberg tumor after surgery for cancer in the digestive tract, it may be better to test the CA-125 tumor marker during the follow-up observation period.
In summary, the incidence of the metastatic ovarian cancer that developed during the follow-up observation period after gastrectomy (Krukenberg tumor) was 3.2%. Even if surgery was performed, the mean survival period was 18.8 months, and the prognosis was poor. Nonetheless, the 3-year survival rate was 15. 
